|
Roth, J A; Cristiano, R J (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89:21-39
|
|
Overholt, S M; Liu, T J; Taylor, D L et al. (1997) Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials. Clin Cancer Res 3:185-91
|
|
Roth, J A (1996) Gene replacement strategies for cancer. Isr J Med Sci 32:89-94
|
|
Mitchell, M F; Hamada, K; Sastry, K J et al. (1996) Transgene expression in the rhesus cervix mediated by an adenovirus expressing beta-galactosidase. Am J Obstet Gynecol 174:1094-101
|
|
Schneider, P M; Casson, A G; Levin, B et al. (1996) Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg 111:323-31;discussion 331-3
|
|
Owen-Schaub, L B; Zhang, W; Cusack, J C et al. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15:3032-40
|
|
Mukhopadhyay, T; Roth, J A (1995) Antisense therapy for cancer. Cancer J Sci Am 1:233-42
|
|
Clayman, G L; el-Naggar, A K; Roth, J A et al. (1995) In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55:1-6
|
|
Fujiwara, T; Grimm, E A; Mukhopadhyay, T et al. (1994) Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54:2287-91
|
|
Roth, J A (1994) Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment. Ann Surg Oncol 1:79-86
|
Showing the most recent 10 out of 32 publications
